Impact of Pathological Characteristics on Local Relapse After Breast-Conserving Therapy: A Subgroup Analysis of the EORTC Boost Versus No Boost Trial The article by Brachtel et al, entitled, “Occult ...

Patients and Methods: Stage IIB (T3N0) to III LABC patients were eligible. Primary chemoradiation consisted of paclitaxel, 30 mg/m 2 delivered intravenously for 1 hour twice weekly for a total of 8 to ...

Breast Reconstruction after Mastectomy. Advances in reconstructive techniques have made breast reconstruction increasingly popular. Reconstruction may be done either at the time of the mastectomy ...